Towa Pharmaceutical Co., Ltd.
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
9/10
|
8.86 | 110.66 | -92% | 15.5 | -42.85% |
| P/S |
|
0.6284 | 75.01 | -99.16% |
|
|
| P/BV |
|
0.9188 | 70.3 | -98.69% |
|
|
| P/FCF |
|
-2.88 | 79.52 | -103.63% |
|
|
| Ev/Ebitda |
|
8.89 | 18.65 | -52.32% |
|
|
| Ev/S |
|
1.39 | 72.39 | -98.09% |
|
|
| Ev/FCF |
|
-10.15 | 24.55 | -141.36% |
|
|
| E/P |
|
0.1802 | -0.1123 | -260.49% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
5/10
|
15.59 | -77.19 | -120.2% | 16.27 | -4.2% |
| ROE |
|
11.05 | -9.19 | -220.17% |
|
|
| ROA |
|
4.03 | -9.6 | -142.01% |
|
|
| ROIC |
|
1.66 | 9.09 | -81.72% |
|
|
| ROS |
|
7.1 | -143.83 | -104.94% |
|
|
| ROCE |
|
11.32 | 6.08 | 86.11% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
0/10
|
5.69 | -1.04 | -646.81% | 5.18 | +9.95% |
| Nеt Debt/Ebitda |
|
4.86 | 12.09 | -59.8% |
|
|
| Debt/Ratio |
|
0.4699 | 0.1394 | 236.98% |
|
|
| Debt/Equity |
|
1.59 | 18.09 | -91.19% |
|
|
| Debt/Net Income |
|
12.51 | -1.95 | -742.19% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
7.65/10
|
3.06 | 2.66 | 14.93% | 2.33 | +31.3% |
| Number of years of dividend growth |
|
0 | 1.27 | -100% | ||
| DSI |
|
0.7857 | 0.7328 | 7.23% |
|
|
| Average dividend growth |
|
-142.91 | -49.62 | 188.03% |
|
|
| Average percentage for 5 years |
|
2.33 | 1.91 | 21.83% |
|
|
| Average percentage for payments |
|
34.22 | 33.37 | 2.55% |
|
|
| Difference from average difference in sector |
|
0.3976 |
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % | ||
|---|---|---|---|---|---|---|
| Growth impulse Revenue in 5 years |
10/10
|
106.5 | 53.88 | 97.66% | ||
| Growth impulse Ebitda in 5 years |
|
38.22 | 12.48 | 206.25% | ||
| Growth impulse Net Income in 5 years |
|
11.54 | -8.53 | -235.29% | ||
| Growth impulse FCF in 5 years |
|
-314.72 | -13.75 | 2188.87% | ||
| Growth impulse EPS in 5 years |
|
20.53 | -67.8 | -130.28% |
IP Score
4.8/10
